Frontlight ResearchEarly access
Trial site
East Coast Institute for Research
- 7running trials
- 7closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes4 trials
- High blood pressure3 trials
- Coronary artery disease2 trials
- Familial hypercholesterolaemia2 trials
- Stroke2 trials
- Type 1 diabetes2 trials
- Atrial fibrillation1 trial
- Diabetic eye disease1 trial
- Heart failure1 trial
- Obesity1 trial
- Phase
- Phase 37 trials
- Phase 24 trials
- Status
- Completed7 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals5 trials
- Novo Nordisk A/S2 trials
- Amgen1 trial
- Diasome Pharmaceuticals1 trial
- East Coast Institute for Research1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Recruiting
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure2 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
- Type 1 diabetes1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026